Back

CCR2-Overexpressing hydrogelated macrophages facilitate targeted lipid clearance and immunomodulation in atherosclerosis treatment

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis: mechanisms, imaging, and therapeutics Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Chenghui Yan

General Hospital of Northern Theater Command, Shenyang (China)

6 More presentations in this session

Presentation thumbnail
Nanotheranostics alleviate vulnerable atherosclerotic plaques through lipid-specific photoacoustic imaging and hypoxic microenvironment modulation
Mr Z. Chen (Hangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Genetic depletion of smooth muscle cells (SMCs) from atheroprogression fundamentally reshapes murine brachiocephalic artery (BCA) lesions
Doctor A. Martinez Navarro (Munich, DE)
Abstract Slides Video
Presentation thumbnail
PI3 kinase-α protects against vascular inflammation, atherosclerosis, and plaque instability by regulating the biology of vascular smooth muscle cells.
Doctor M. Zierden (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
The asialoglycoprotein receptor 1, the glycome, and proteome associate with coronary atherosclerosis progression on serial photon-counting coronary computed tomography angiography
Doctor N. Wattchow (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Elevated remnant cholesterol explains a substantial part of excess cardiovascular risk in the metabolic syndrome
Doctor K. Hvid (Herlev, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Atherosclerosis: mechanisms, imaging, and therapeutics

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Session
Novel targets for treatment of atherosclerosis
26 August 2023
thumbnail
Congress Presentation
Non-clinical evaluation of YN001-a promising drug for atherosclerotic therapy by targeted delivery system
25 August 2023
thumbnail
Congress Presentation
HDL-associated phosphatidylserine normalizes vessel wall metabolism and architecture in atherosclerosis
1 September 2025
thumbnail
Congress Presentation
PCSK9i and atherosclerotic plaque regression assessed by coronary computed tomography angiography
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources